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by PET/CT scan. No difference in staging was seen in 26 cases (37%). 
3 cases (4%) could not be assessed because of incomplete records. 
In 19 out of 67 cases (28%) PET/CT scan changed the management 
decision from radical to palliative treatment and in 11 cases (17%) 
the management changed from palliative to radical treatment. Overall 
the difference in staging led to a change in management in 30 patients 
(45%). Congruent results were seen in 37 cases (55%).
Conclusion: This was a small retrospective study. However, it 
conﬁrmed that PET/CT is invaluable for the correct management of 
NSCLC patients. This ﬁgure is consistent with current literature where 
40-45% of changes in management are quoted. 
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Role of PET in evaluation of lung cancer
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PET is a widely used diagnostic method of nuclear radiology in the 
diagnosis and evaluation of malignancies. Apart from other malignan-
cies PETespecially has an important role in diagnosis, staging and 
therapy of lung cancer in our daily practice. In this study we evaluated 
retrospectively our patients whom PET was used during their therapies. 
Prediagnosis of the patients, the role of PET in disease staging, and the 
role of PET in therapy changes were analised. 34 patients were evalu-
ated, consisting 30 male, 4 female. The patients median age was 55. 
PET, was performed to ﬁnd the primery site of metastasis in 11 cases, 
primary tumor relaps after lung cancer surgery in 4 cases, preoperative 
assesement in 14 cases and for staging after neuadjuvant therapy in 5 
cases. PET staging made the clinic stage up in 13 of 23 lung cancer 
patients and down in 4 patient. In 6 patients PET didn’t change the 
clinic stage. 
Conclusion: PET should be thought in stagingthe lung cancer patients 
especially who will be planned to treat with invazive therapy modalities
P1-074 Imaging and Staging Posters, Mon, Sept 3 
Lung cancer cases detected by repeated low-dose CT screening
Kondo, Tetsuro Mori, Kiyoshi Kodama, Tetsuro 
Dept. of Thoracic Disease, Tochigi Cancer Center, Utsunomiya, Japan
Purpose: To review lung cancer cases detected by repeated low-dose 
CT screening, and then to clarify pitfalls in interpretation and observa-
tion of repeated screenee.
Methods: From May 2000 to March 2005, asymptomatic 4,176 sub-
jects (2,490 male and 1,686 female) underwent low-dose CT screening. 
A total 13 subjects were found to have lung cancer over a period of 5 
years. Among them, 3 cases were repeated screenee case. These 3 cases 
were reviewed gender, age, smoking pack years, tumor size, histologi-
cal subtype, disease stage and repeated CT images.
Results: Case one was 61 years old female with well differentiated ad-
enocarcinoma of stage IA disease. She underwent 3 times of CT screen-
ing until diagnosed lung cancer. First time her lesion was estimated 
post inﬂammatory scar, but it was gradually grown in size. Second case 
was 66 years old male with small cell carcinoma of stage IIA disease. 
He underwent 4 times of CT screening until diagnosed lung cancer. 
Until second repeated CT screening, his thoracic CT images were no 
evidence of disease. In 3rd CT screening, he was detected small nodule 
in peripheral lung, but it was disappeared. In 4th CT screening, left 
hilar lymphadenopathy was detected. Trans-bronchial biopsy specimen 
proved small cell carcinoma. Third case was 58 years old male with 
squamous cell carcinoma of stage IIIA disease. He underwent 2 times 
of CT screening until diagnosed lung cancer. He was detected a nodule 
in ﬁrst CT screening, but it was estimated decreased in size. In second 
CT screening, this nodule was grown in size again. First case of female 
was never-smoker, but second and third cases were 92 and 38 pack-
years smoker, respectively.
Conclusions: Many of the lung cancers detected by low-dose CT 
screening were early stage disease. On the other hand, there is rapid 
growth case in a short period, we must remember these case can be 
detected by faint change in a comparative interpretation and a strict 
observation. Especially, nodules detected in heavy-smoking screenee 
must be paid attention to the faint change.
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Combined endoscopic transbronchial and transesophageal 
ultrasound-guided biopsy of centrally located lung tumours 
following a nondiagnostic bronchoscopy
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Objective: The aim of the present study was to test the use of EBUS 
TBNA and EUS FNA in patients with an undiagnosed solid lesion of 
unknown origin in the lung or mediastinum
Methods: 
EBUS TBNA and EUS FNA was performed before mediastinoscopy.
52 patients prospective referred - 5 patients with a tumour in the medi-
astinum 47 patients with an undiagnosed tumour in the lung.
Bronchoscopy and TBNA had been performed in all patients without 
obtaining a diagnose.
103 lymph nodes and 5 tumours were biopsied
All the diagnosis was confrmed either by mediastinoscopy, thoracoto-
my/ thoracoscopy
Results: 
103 lymph nodes and 5 tumours were biopsied
EBUS TBNA positive for cancer in 34 lymph nodes
EUS FNA positive for cancer in 37 lymph nodes 
EUS and EBUS positive for cancer in 2 tumours
EUS and EBUS showed speciﬁc benign changes i 3 tumours
In one patient both EUS FNA and EBUS TBNA shoved benign changes 
and a cancer was found in a N1 lymph nodes during operation
3 biopsies were inconclusive and 32 lymph nodes biopsies showed cor-
rectly normal lymph cells 
The diagnostic yield was 97% (105/108) 
31 patients were diagnosed with a malignant diagnosis and 3 patients 
with a speciﬁc benign diagnosis
